Episode 1: Maintenance Rituximab for Waldenström Macroglobulinemia

Treon & Buske

On this episode of Blood Bytes, a hematology podcast produced by Oncology Learning Network, Steven Treon, MD, PhD, Director of the Bing Center for Waldenström’s macroglobulinemia at the Dana-Farber Cancer Institute, and Professor of Medicine at Harvard Medical School, Boston, sits down with Christian Buske, MD, Medical Director at the Comprehensive Cancer Center and the Institute of Experimental Cancer Research at the University Ulm, Germany, to discuss recent data surrounding the use of rituximab maintenance for patients with Waldenström macroglobulinemia.


7 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Stay in the know.
OncNet Newsletter